Funding to accelerate scalable commercial production of pharmaceutical grade QS-21 for human vaccines, R&D lab expansion, opening new markets for vaccine developers. DAVIS, Calif.--(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results